Lilly's And Schering's Blockbuster Hangovers
Forbes - 24 Jan 2003
... Strattera, a nonstimulant treatment for attention deficit disorder, and osteoporosis
drug Forteo have both been approved by the FDA and launched in the past ...

Strong quarter caps '02 for Lilly
Indianapolis Star, IN - 23 Jan 2003
... Two drugs hit the US market in the past few weeks: Strattera for attention-deficit
hyperactivity disorder and Forteo for osteoporosis. ...

Lilly Posts Profit, but Issues Warning
ABC News - 23 Jan 2003
... It won approval in November for two long-delayed medicines, Strattera
for attention deficit disorder and Forteo for osteoporosis. ...

Lilly Posts Profit, but Issues Warning
Reuters, UK - 23 Jan 2003
... It won approval in November for two long-delayed medicines, Strattera
for attention deficit disorder and Forteo for osteoporosis. ...

Lilly Posts 28 Percent Earnings Increase
Austin American Statesman, TX - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

Lilly Posts 28 Percent Earnings Increase
ABC News - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

Lilly Posts 28 Percent Earnings Increase
Kansas City Star, MO - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

Lilly Earnings Rise, but Shares Fall
ABC News - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

3 Drugmakers Post Gains, 2003 Seen Hard
ABC News - 23 Jan 2003
... He said Lilly should emerge strong after 2003 because of the recent approval of
its drug Strattera for attention deficit disorder and expected approval this ...

Lilly's And Schering's Blockbuster Hangovers
Forbes - 23 Jan 2003
... Strattera, a nonstimulant treatment for attention deficit disorder, and osteoporosis
drug Forteo have both been approved by the FDA and launched in the past ...

Lilly's And Schering's Blockbuster Hangovers
Forbes - 23 Jan 2003
... Strattera, a nonstimulant treatment for attention deficit disorder, and osteoporosis
drug Forteo have both been approved by the FDA and launched in the past ...

3 Drugmakers Post Gains, 2003 Seen Hard
Reuters, UK - 23 Jan 2003
... He said Lilly should emerge strong after 2003 because of the recent approval of
its drug Strattera for attention deficit disorder and expected approval this ...

Lilly Posts 28 Percent Earnings Increase
Austin American Statesman, TX - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Springfield News Sun, OH - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Seattle Times, WA - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
ABC News - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
ABC News - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
San Jose Mercury News, CA - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Miami Herald, FL - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
ABC News - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Sarasota Herald-Tribune, FL - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Springfield News Sun, OH - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Lakeland Ledger, FL - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Seattle Post Intelligencer, WA - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly's Fourth Quarter Marks a Return to Quarterly Sales Growth ...
BusinessWire (press release) - 23 Jan 2003
... Strattera(TM) was approved by the US Food and Drug Administration (FDA) for the
treatment of attention-deficit hyperactivity disorder (ADHD) in children ...

5 For Kids: New ADHD Drug
WLWT, OH - 20 Jan 2003
... But now, there is a new drug on the market known as Strattera. It's the first FDA
approved non-stimulant that manufacturers say will offer fewer side-effects. ...

Drugmakers Rx: can't get much worse
CNN Europe, Europe - 20 Jan 2003
... As for Eli Lilly, in November it won federal marketing approval for
Strattera, to treat attention deficit hyperactivity disorder. ...

Drugmakers Rx: can't get much worse
CNN/Money - 20 Jan 2003
... As for Eli Lilly, in November it won federal marketing approval for
Strattera, to treat attention deficit hyperactivity disorder. ...

Eli Lilly: Straterra likely to narrow revenue deficit
UK Comment Wire, UK - 17 Jan 2003
January 17, 2003 12:50 PM GMT (Datamonitor) - Eli Lilly's Strattera
is set to add a new dimension to the US ADHD market. It is the ...

Lilly's ADHD drug hits the market
Indianapolis Star, IN - 15 Jan 2003
... Strattera is expected to be a major seller for the Indianapolis drugmaker as a
treatment for attention-deficit/hyperactivity disorder in both children and ...

Daily briefing
The News Journal, DE - 15 Jan 2003
... Eli Lilly and Co., which won federal marketing approval for Strattera
in November, said more than 46000 pharmacies have stocked the drug.

New Lilly drug expects promising sales
WTHR, IN - 14 Jan 2003
Cathie's son took part in a clinical trial on the Eli Lilly and Company
drug Strattera. It hit pharmacy shelves Tuesday. Strattera ...

Lilly's Attention Deficit Drug Available
WMAR (ABC2), MD - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

New attention deficit drug hits US pharmacies
CTV, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's new attention deficit drug Strattera hits US pharmacies
Ottawa Citizen, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's new attention deficit drug Strattera hits US pharmacies
St. Catharines Standard, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's new attention deficit drug Strattera hits US pharmacies
Canada.com, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

New Lilly drug arrives in pharmacies
Indianapolis Star, IN - 14 Jan 2003
... Strattera is expected to be a major seller for the Indianapolis drugmaker as a
treatment for attention-deficit/hyperactivity disorder in both children and ...

Lilly's Attention Deficit Drug Available
Sarasota Herald-Tribune, FL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's Attention Deficit Drug Available
ABC News - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's Attention Deficit Drug Available
Lakeland Ledger, FL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's Attention Deficit Drug Available
Times Daily, AL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's Attention Deficit Drug Available
Newsday - 14 Jan 2003
... Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's New ADHD Drug Now Available in Pharmacies
WISH, IN - 14 Jan 2003
... in pharmacies. The drug is called Strattera and is the first non-stimulant
drug approved by the FDA for treating ADHD. Lilly says ...

Lilly's new attention deficit drug hits pharmacies
Miami Herald, FL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Shire Pharma shares hit by threat to lead drug
Independent, UK - 09 Jan 2003
... Eli Lilly, the US pharmaceutical giant, has recently launched Strattera,
a new kind of drug for hyperactive children and adults. ...

Strattera May Help With Hyperactivity Disorder
Newsday - 07 Jan 2003
... As the dose wears off he gets pretty hyper and has trouble getting to sleep. A.
Ask his doctor if Strattera might be appropriate. It has just been approved. ...

Drugs: Relief from the Pain
BusinessWeek - 06 Jan 2003
... Eli Lilly & Co. (LLY ) is also likely to launch Strattera, for attention-deficit
hyperactivity disorder, and a new antidepressant called Cymbalta. ...

Business had year of ups and downs
Indianapolis Star, IN - 29 Dec 2002
... its plants. As the drugmaker adjusts to the new regulations, two other
drugs Ñ Forteo and Strattera Ñ are approved. IPL's immediate ...